Eye Health Supplements Market Size, Share, Growth, Trends, Company Analysis, Regional Insights and Forecast 2020 - 2027

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Eye Health Supplements Market, By Indication

7.1.  Eye Health Supplements Market, By Indication Type, 2020-2030

7.1.1.    Age-related Macular Degeneration (AMD)

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Cataract

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    Dry Eye Syndrome

7.1.3.1.        Market Revenue and Forecast (2016-2030)

7.1.4.    Inflammation

7.1.4.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Eye Health Supplements Market, By Formulation

8.1.  Eye Health Supplements Market, By Formulation, 2020-2030

8.1.1.    Tablets

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Capsules

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Powder

8.1.3.1.        Market Revenue and Forecast (2016-2030)

8.1.4.    Softgels

8.1.4.1.        Market Revenue and Forecast (2016-2030)

8.1.5.    Liquid

8.1.5.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Eye Health Supplements Market, By Ingredient Type

9.1.  Eye Health Supplements Market, By Ingredient Type, 2020-2030

9.1.1.    Lutein and Zeaxanthin

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Antioxidants

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    Omega-3 Fatty acids

9.1.3.1.        Market Revenue and Forecast (2016-2030)

9.1.4.    Coenzyme Q10

9.1.4.1.        Market Revenue and Forecast (2016-2030)

9.1.5.    Flavonoids

9.1.5.1.        Market Revenue and Forecast (2016-2030)

9.1.6.    Alpha-Lipoic Acid

9.1.6.1.        Market Revenue and Forecast (2016-2030)

9.1.7.    Astaxanthin

9.1.7.1.        Market Revenue and Forecast (2016-2030)

9.1.8.    Other Supplements

9.1.8.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Eye Health Supplements Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, By Indication (2016-2030)

10.1.2.  Market Revenue and Forecast, By Formulation (2016-2030)

10.1.3.  Market Revenue and Forecast, By Ingredient Type (2016-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, By Indication (2016-2030)

10.1.4.2.      Market Revenue and Forecast, By Formulation (2016-2030)

10.1.4.3.      Market Revenue and Forecast, By Ingredient Type (2016-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, By Indication (2016-2030)

10.1.5.2.      Market Revenue and Forecast, By Formulation (2016-2030)

10.1.5.3.      Market Revenue and Forecast, By Ingredient Type (2016-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, By Indication (2016-2030)

10.2.2.  Market Revenue and Forecast, By Formulation (2016-2030)

10.2.3.  Market Revenue and Forecast, By Ingredient Type (2016-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, By Indication (2016-2030)

10.2.4.2.      Market Revenue and Forecast, By Formulation (2016-2030)

10.2.4.3.      Market Revenue and Forecast, By Ingredient Type (2016-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, By Indication (2016-2030)

10.2.5.2.      Market Revenue and Forecast, By Formulation (2016-2030)

10.2.5.3.      Market Revenue and Forecast, By Ingredient Type (2016-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, By Indication (2016-2030)

10.2.6.2.      Market Revenue and Forecast, By Formulation (2016-2030)

10.2.6.3.      Market Revenue and Forecast, By Ingredient Type (2016-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, By Indication (2016-2030)

10.2.7.2.      Market Revenue and Forecast, By Formulation (2016-2030)

10.2.7.3.      Market Revenue and Forecast, By Ingredient Type (2016-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, By Indication (2016-2030)

10.3.2.  Market Revenue and Forecast, By Formulation (2016-2030)

10.3.3.  Market Revenue and Forecast, By Ingredient Type (2016-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, By Indication (2016-2030)

10.3.4.2.      Market Revenue and Forecast, By Formulation (2016-2030)

10.3.4.3.      Market Revenue and Forecast, By Ingredient Type (2016-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, By Indication (2016-2030)

10.3.5.2.      Market Revenue and Forecast, By Formulation (2016-2030)

10.3.5.3.      Market Revenue and Forecast, By Ingredient Type (2016-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, By Indication (2016-2030)

10.3.6.2.      Market Revenue and Forecast, By Formulation (2016-2030)

10.3.6.3.      Market Revenue and Forecast, By Ingredient Type (2016-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, By Indication (2016-2030)

10.3.7.2.      Market Revenue and Forecast, By Formulation (2016-2030)

10.3.7.3.      Market Revenue and Forecast, By Ingredient Type (2016-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, By Indication (2016-2030)

10.4.2.  Market Revenue and Forecast, By Formulation (2016-2030)

10.4.3.  Market Revenue and Forecast, By Ingredient Type (2016-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, By Indication (2016-2030)

10.4.4.2.      Market Revenue and Forecast, By Formulation (2016-2030)

10.4.4.3.      Market Revenue and Forecast, By Ingredient Type (2016-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, By Indication (2016-2030)

10.4.5.2.      Market Revenue and Forecast, By Formulation (2016-2030)

10.4.5.3.      Market Revenue and Forecast, By Ingredient Type (2016-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, By Indication (2016-2030)

10.4.6.2.      Market Revenue and Forecast, By Formulation (2016-2030)

10.4.6.3.      Market Revenue and Forecast, By Ingredient Type (2016-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, By Indication (2016-2030)

10.4.7.2.      Market Revenue and Forecast, By Formulation (2016-2030)

10.4.7.3.      Market Revenue and Forecast, By Ingredient Type (2016-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, By Indication (2016-2030)

10.5.2.  Market Revenue and Forecast, By Formulation (2016-2030)

10.5.3.  Market Revenue and Forecast, By Ingredient Type (2016-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, By Indication (2016-2030)

10.5.4.2.      Market Revenue and Forecast, By Formulation (2016-2030)

10.5.4.3.      Market Revenue and Forecast, By Ingredient Type (2016-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, By Indication (2016-2030)

10.5.5.2.      Market Revenue and Forecast, By Formulation (2016-2030)

10.5.5.3.      Market Revenue and Forecast, By Ingredient Type (2016-2030)

Chapter 11.  Company Profiles

11.1.              The Nature's Bounty Co.

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              Vitabiotics Ltd.

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              Pfizer Inc.

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              Amway International

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              Bausch & Lomb

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              Nutrivein

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              ZeaVision LLC

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              Kemin Industries, Inc.

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              EyeScience

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

11.10.           Nutrachamps

11.10.1.               Company Overview

11.10.2.               Product Offerings

11.10.3.               Financial Performance

11.10.4.               Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

Glossary of Terms